In xenograft models, CAR-CD3+CD4−CD8− T cells demonstrated efficient infiltration and tumor suppression against lung cancer genetically engineered to produce CD19, as well as antigen-specific cytotoxicity against B cell acute lymphoblastic leukemia [176]. This evidence concerns the gene CD19 and neoplasm.